Table 7 Predictors of baseline characteristics in multivariate logistic regression analysis in patients with heart failure.

From: Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study

Parameters

Univariate analysis

Multivariate anaysis

OR

95% CI

P value

OR

95% CI

P value

Age, years

1.043

1.018–1.069

0.518

   

Body mass index, kg/m2

1.024

0.913–1.118

0.406

   

Sex

0.731

0.393–1.358

0.321

   

Hypertension

1.281

0.553–2.968

0.563

   

Coronary artery disease

1.081

0.525–2.223

0.833

   

Systolic blood pressure, mmHg

1.013

0.979–1.049

0.461

1.016

0.980–1.053

0.395

Diastolic blood pressure, mmHg

0.987

0.939–1.038

0.619

0.985

0.935–1.038

0.572

Heart rate, bpm

1.024

0.983–1.067

0.254

1.020

0.978–1.064

0.359

BNP, pg/ml

1.023

1.004–1.025

0.003**

1.008

1.006–1.012

0.002**

Plasma LDL-c, mmol/l

0.589

0.042–8.191

0.694

0.855

0.076–9.681

0.900

Plasma HDL-c, mmol/l

0.652

0.038–11.191

0.768

0.938

0.066–13.292

0.962

Plasma total cholesterol, mmol/l

1.465

0.101–21.362

0.780

0.973

0.082–11.532

0.983

Plasma triglyceride, mmol/l

0.733

0.212–2.530

0.623

0.853

0.269–2.707

0.787

Plasma Apelin, pg/ml

1.005

1.002–1.009

0.004**

1.015

1.003–1.017

0.001**

Plasma ELABELA, ng/ml

0.731

0.666–0.801

 < 0.001***

0.722

0.658–0.791

 < 0.001***

LVEF, %

0.974

0.915–1.037

0.412

0.958

0.901–1.019

0.177

LAD, mm

1.088

1.011–1.172

0.025*

1.098

1.021–1.181

0.012*

  1. CI, confidence interval; OR, odds ratio; BNP, B-type natriuretic peptide; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol. *P < 0.05; **P < 0.01;***P < 0.001.
  2. Significant values are in bold.
Back to article page